The pharmaceutical industry won a stunning victory today in the UK Court of Appeal over the Government’s value-for-money watchdog.
NICE, the National Institute for Health and Clinical Excellence, had acted unfairly in refusing to allow Eisai and Pfizer full access to a computer model used to assess the cost-effectiveness of Aricept, an Alzheimer’s drug, the court ruled.
More at The Times
No comments:
Post a Comment